Vimarsana
Biggest News Aggregation in the World

Page 48 - Self Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Self Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Self Test Today - Breaking & Trending Today

In-Depth: The simple change that made rapid COVID tests reliable - Vimarsana News

In-Depth: The simple change that made rapid COVID tests reliable

In-Depth: The simple change that made rapid COVID tests reliable Over-the-counter rapid tests get FDA go-ahead The authorization from the FDA represents a significant endorsement that rapid diagnostics are accurate and effective in even the most challenging testing scenario: evaluating people who are not showing symptoms. and last updated 2021-04-01 21:26:05-04 SAN DIEGO (KGTV) -- COVID-19 self-tests that offer on-the-spot results in minutes will start hitting pharmacy shelves this month, with no prescription required. The Food and Drug Administration granted emergency authorization Wednesday...

Source: 10news.com
Coronavirus (COVID-19) Update: FDA Continues to Advance Over-the Counter and Other Screening Test Development - Vimarsana News

Coronavirus (COVID-19) Update: FDA Continues to Advance Over-the Counter and Other Screening Test Development

Share this article Share this article SILVER SPRING, Md., March 31, 2021 /PRNewswire/ -- Following recent U.S. Food and Drug Administration actions to support test development, the FDA took swift action this week to get more tests for screening asymptomatic individuals on the market. Today, the agency authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening. In addition to the tests authorized for OTC use, one serial screening test was authorized for use in a point-of-care (POC) setting without a prescription, and an additional screening te...

Abbott's BinaxNOW Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use - Vimarsana News

Abbott's BinaxNOW Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use

Abbott  announced today it has received U.S. Food and Drug Administration Emergency Use Authorization for over-the-counter, non-prescription, asymptomatic use of its BinaxNOW™ COVID-19 Ag Self Test for detection of COVID-19 infection. This new indication allows individuals with or without symptoms to have access to this test without a prescription. Abbott will begin shipping to major food, drug and mass ...

Abbott's BinaxNOW™ Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use - Vimarsana News

Abbott's BinaxNOW™ Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use

Share this article Share this article ABBOTT PARK, Ill., March 31, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non-prescription, asymptomatic use of its BinaxNOW™ COVID-19 Ag Self Test for detection of COVID-19 infection. This new indication allows individuals with or without symptoms to have access to this test without a prescription. Abbott will begin shipping to major food, drug and mass merchandiser retailers in the coming weeks and expect the test to be availab...

FDA takes action to advance OTC and other screening test development - Vimarsana News

FDA takes action to advance OTC and other screening test development

Following recent U.S. Food and Drug Administration actions to support test development, the FDA took swift action this week to get more tests for screening asymptomatic individuals on the market. Today, the agency authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening.